Replies to post #77369 on Anavex Life Sciences Corp (AVXL)

[512]

The comparison is Absurd. It is the best they(cabal) can come up with to counter the 2 recent pr's. Charles Schwab is paying a premium to borrow shares, although not as high as last time.

[bas2020]

I'll want to see the comparison when AVXL has a MC of $4B, like Ionis. That is, if AVXL's valuation stops at $4B. :)